Medtronic's profit forecast hit by stronger dollar, inflation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- Kroger cuts same-store sales outlook, keeps earnings guidance
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Medtronic, Inc. (MDT) PT Raised to $100 at Evercore ISI, 'we find MDT compelling in a choppy macro environment'
May 25, 2023 11:15 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Medtronic, Inc. (NYSE: MDT) to $100.00 (from $88.00) while maintaining a Outperform rating.
The analyst comments "Generally, inlinish results (vs expecs) and Guide are not reasons to be cheeringbut given the uniqueness of MDT situation, we see the 4Q print as a clearing event and time for investors to get incrementally constructive. For background, MDT has had a tough 18 months, starting with the late 2021 triple whammy of Diabetes warning letter, RDN headline miss and pushout of robotics. This... More
Deutsche Bank Keeps Hold Rating on Medtronic, Inc. (MDT), 'Good, but maybe not quite good enough'
May 25, 2023 11:13 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Net-net. The debate heading into the quarter was simple: (1) What does 4Q results imply about guidance; (2) Is FY 2024 guidance a... More
